News


星洲日報 大都會十月十四日  2010年
心肌症1年內可致命
留意症狀勿掉以輕心


光明日報/良醫 三月二十四日  2010年
大馬首宗‧幹細胞治漸凍人

光明日報/良醫 一月十二日  2010年
幹細胞移殖助心臟衰竭者
活化細胞再生心肌


光明日報/良醫 八月四日  2009年
具多重分化功能增生軟骨
間充質幹細胞治關節炎


星洲日報 馬六甲,古城八月二日  2009年
對風濕神經線損壞效果佳
乾細胞治療引進古城


星洲日報 大都會七月十五日  2009年
只需注射一針,幹細胞治關節炎

中國報 森美蘭,芙蓉四月九日  2009年
接受膝蓋軟骨幹細胞治療

光明日報/良醫  三月二十七日  2009年
幹細胞新療法系列(上)
間充質幹細胞再造心肌‧提高心臟泵血力度


光明日報/良醫 三月二十八日  2009年
幹細胞新療法系列(下)
接受幹細胞新療法‧須血管暢通血液足


光明日報/良醫 十一月二十一日  2008年
骨髓幹細胞‧可重建新血管

Cytopeutics is one of the leading and responsible pioneers in stem cell research and treatment. After more than a decade of evidence-based research and development, combining the expertise of scientists around the world, Cytopeutics is now ready to offer its capabilities to help people with diseases that were previously deemed incurable.

 

At Cytopeutics, our goal is to bring comprehensive stem cell treatment solutions to Malaysia and Asia Pacific Region so that lives can be improved for the better.  We currently have concluded our stem cell research in heart failures, heart attack, refractory angina, osteoarthritis (knee) and diabetic foot ulcer, and we will progressively offer proven treatments under observation.

 

Our pilot treatments are conducted with utmost professionalism. Presently our treatment uses only the patients? own stem cell.  Under our patented technology and protocol, the calls are handled under the strictest standards, in a certified clean room environment and transplanted to patient only by highly qualified professionals.




Updated on 26th February 2009  |  Privacy Policy  |  Disclaimer  |  Copyright © Cytopeutics Sdn. Bhd